Login to Your Account

Financings Roundup

Wednesday, May 30, 2012
• Cell Therapeutics Inc., of Seattle, said it will sell $40 million of shares of Series 15 convertible preferred stock and warrants to purchase shares of common stock in a registered direct offering to an institutional investor in two tranches of $20 million each.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription